Aim
Cancer
METASTATIC GASTRIC CANCER, CANCER
Edited by: Yuming Jiang, Wake Forest University, United StatesReviewed by: Zibing Wang, Henan Provincial Cancer Hospital, China; Lu Han, Henan Provincial Cancer Hospital, ChinaTo evaluate the safety and initial efficacy of autologous cytokine-induced killer (CIK) cells combined with S-1+oxaliplatin (SOX) as the first-line treatment for locally advanced or metastatic gastric cancer (GC).